Corbus Pharmaceuticals Holdings (CRBP) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -13.32% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 17.12% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -14.18% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 24.11% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | -58.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.70% |
| Sep 30, 2025 | -61.27% |
| Jun 30, 2025 | -62.59% |
| Mar 31, 2025 | -63.00% |
| Dec 31, 2024 | -60.43% |
| Sep 30, 2024 | -53.69% |
| Jun 30, 2024 | -47.31% |
| Mar 31, 2024 | -42.63% |
| Dec 31, 2023 | -39.71% |
| Sep 30, 2023 | -37.67% |
| Jun 30, 2023 | -35.97% |
| Mar 31, 2023 | -35.22% |
| Dec 31, 2022 | -32.55% |
| Sep 30, 2022 | -32.22% |
| Jun 30, 2022 | -43.46% |
| Mar 31, 2022 | -41.64% |
| Dec 31, 2021 | -41.18% |
| Sep 30, 2021 | -39.74% |
| Jun 30, 2021 | -22.64% |
| Mar 31, 2021 | -21.93% |